Informações de Insulet Corp

Mais detalhes de Insulet Corp Empresa

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.



Código da empresaPODD

Nome da EmpresaInsulet Corp

Data de listagemMay 15, 2007

CEOMs. Ashley Mcevoy

Número de funcionários3900

Tipo de títulosOrdinary Share

Fim do ano fiscalMay 15

Endereço100 Nagog Park

CidadeACTON

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal01720-3440

Telefone19786007000

Sitehttps://www.omnipod.com

Código da empresaPODD

Data de listagemMay 15, 2007

CEOMs. Ashley Mcevoy

Executivos da empresa Insulet Corp



Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

--

Mr. Prem Singh

Senior Vice President - Global Operations

3.56K

-16.16%

Dr. Luciana Borio, M.D.

Independent Director

3.09K

-13.48%

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.89K

+36.78%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

Por EmpresaUSD

Nome

Receita

Proporção

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

Por RegiãoUSD

Nome

Receita

Proporção

United States

463.30M

71.38%

All Other

185.80M

28.62%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

Distribuição de ações

Atualizado em: ter, 19 de ago

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

Outro

60.68%

Investidores

Proporção

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

Outro

60.68%

Tipos de investidores

Investidores

Proporção

Investment Advisor

64.61%

Investment Advisor/Hedge Fund

23.75%

Hedge Fund

5.78%

Research Firm

2.96%

Pension Fund

2.15%

Sovereign Wealth Fund

1.60%

Bank and Trust

1.22%

Individual Investor

0.30%

Private Equity

0.09%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

1522

71.86M

102.08%

-3.62M

2025Q2

1541

72.80M

103.47%

-3.81M

2025Q1

1569

72.82M

103.50%

-3.52M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

8.68M

12.33%

+38.89K

+0.45%

Jun 30, 2025

Fidelity Management & Research Company LLC

6.86M

9.74%

-271.19K

-3.80%

Jun 30, 2025

Capital Research Global Investors

4.74M

6.73%

-1.34M

-22.06%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

4.35M

6.18%

-13.40K

-0.31%

Jun 30, 2025

State Street Investment Management (US)

3.06M

4.34%

+32.74K

+1.08%

Jun 30, 2025

Baillie Gifford & Co.

2.14M

3.03%

-115.69K

-5.14%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.93M

2.74%

+58.31K

+3.12%

Jun 30, 2025

ClearBridge Investments, LLC

1.54M

2.18%

+56.63K

+3.83%

Jun 30, 2025

American Century Investment Management, Inc.

1.31M

1.86%

+157.07K

+13.63%

Jun 30, 2025

Fidelity International

1.13M

1.61%

-155.38K

-12.09%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: seg, 6 de out

Nome

Proporção

Langar Global HealthTech ETF

6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

4.97%

Goldman Sachs Future Health Care Equity ETF

4.91%

Global X HealthTech ETF

4.42%

Fidelity Digital Health ETF

4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

3.4%

Congress SMid Growth ETF

2.99%

iShares U.S. Medical Devices ETF

2.74%

iShares Health Innovation Active ETF

2.64%

FT Raymond James Multicap Growth Equity ETF

2.54%

Ver Mais

Langar Global HealthTech ETF

Proporção6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporção4.97%

Goldman Sachs Future Health Care Equity ETF

Proporção4.91%

Global X HealthTech ETF

Proporção4.42%

Fidelity Digital Health ETF

Proporção4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

Proporção3.4%

Congress SMid Growth ETF

Proporção2.99%

iShares U.S. Medical Devices ETF

Proporção2.74%

iShares Health Innovation Active ETF

Proporção2.64%

FT Raymond James Multicap Growth Equity ETF

Proporção2.54%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados